Characterization of HIV-1 drug resistance causing second-line combined antiretroviral therapy failure in Ethiopia

被引：0
|
作者：
Fuchs, Andre [1 ]
Tufa, Tafese Beyene [1 ]
Orth, Hans Martin [1 ]
Luebke, Nadine [2 ]
Knops, Elena [3 ]
Heger, Eva [3 ]
Jarso, Godana [4 ]
Hurissa, Zewdu [5 ]
Haussinger, Dieter [1 ]
Luedde, Tom [1 ]
Jensen, Bjorn-Erik Ole [1 ]
Kaiser, Rolf [3 ]
Feldt, Torsten [1 ]
机构：
[1] Hirsch Inst Trop Med, Assela, Ethiopia
[2] Univ Klin Dusseldorf, Dusseldorf, Germany
[3] Univ Klin Koln, Cologne, Germany
[4] Adama Hosp Med Coll, Adama, Ethiopia
[5] Arsi Univ, Asella, Ethiopia
来源：
INFECTION | 2021年 / 49卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
033
引用
收藏
页码：S19 / S20
页数：2
相关论文
共 50 条
  • [31] Effectiveness of Second-Line Antiretroviral Therapy: The Impact of Drug Switches
    Braga, Leticia P.
    Mendicino, Cassia C. P.
    Reis, Edna A.
    Carmo, Ricardo A.
    Menezes de Padua, Cristiane A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 346 - 346
  • [32] Emergence of HIV Drug Resistance During First- and Second-Line Antiretroviral Therapy in Resource-Limited Settings
    Hosseinipour, Mina C.
    Gupta, Ravindra K.
    Van Zyl, Gert
    Eron, Joseph J.
    Nachega, Jean B.
    JOURNAL OF INFECTIOUS DISEASES, 2013, 207 : S49 - S56
  • [33] Resistance in Pediatric Patients Experiencing Virologic Failure With First-line and Second-line Antiretroviral Therapy
    Orrell, Catherine
    Levison, Julie
    Ciaranello, Andrea
    Bekker, Linda-Gail
    Kuritzkes, Daniel R.
    Freedberg, Kenneth A.
    Wood, Robin
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (06) : 644 - 647
  • [34] Factors associated with the failure of first and second-line antiretroviral therapies therapy, a case control study in Cambodian HIV-1 infected children Pediatrics
    Barennes H.
    Virak K.
    Rouet F.
    Buisson Y.
    Strobel M.
    Vibol U.
    BMC Research Notes, 9 (1)
  • [35] Drug Resistance Among Adolescents and Young Adults with Virologic Failure of First-Line Antiretroviral Therapy and Response to Second-Line Treatment
    Kouamou, Vinie
    Varyani, Bhavini
    Shamu, Tinei
    Mapangisana, Tichaona
    Chimbetete, Cleophas
    Mudzviti, Tinashe
    Manasa, Justen
    Katzenstein, David
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2020, 36 (07) : 566 - 573
  • [36] HIV protease resistance mutations in patients receiving second-line antiretroviral therapy in Libreville, Gabon
    Nzengui-Nzengui, Guy Francis
    Mourembou, Gael
    M'boyis-Kamdem, Herve
    Kombila-Koumavor, Ayawa Claudine
    Ndjoyi-Mbiguino, Angelique
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [37] HIV protease resistance mutations in patients receiving second-line antiretroviral therapy in Libreville, Gabon
    Guy Francis Nzengui-Nzengui
    Gaël Mourembou
    Hervé M’boyis-Kamdem
    Ayawa Claudine Kombila-Koumavor
    Angélique Ndjoyi-Mbiguino
    BMC Infectious Diseases, 24
  • [38] HIV patients' decision of switching to second-line antiretroviral therapy in India
    de Mello-Sampayo, Felipa
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2015, 27 (07): : 900 - 906
  • [39] Prevalence of HIV-1 drug resistance among patients with antiretroviral therapy failure in Moscow region, Russia
    Lebedeva, N.
    Pronin, A.
    HIV MEDICINE, 2019, 20 : 175 - 175
  • [40] Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
    Abdissa, Alemseged
    Yilma, Daniel
    Fonager, Jannik
    Audelin, Anne M.
    Christensen, Lone H.
    Olsen, Mette F.
    Tesfaye, Markos
    Kaestel, Pernille
    Girma, Tsinuel
    Aseffa, Abraham
    Friis, Henrik
    Pedersen, Court
    Andersen, Aase B.
    BMC INFECTIOUS DISEASES, 2014, 14
12345